Missouri is solidifying its role as a national leader in reshoring active pharmaceutical ingredient (API) research and development. With a strong presence of human health and API-focused businesses, the state is ... Read More
In a groundbreaking step toward combating global water pollution, scientists at the University of Missouri (Mizzou) have developed a liquid-based solution capable of removing more than 98% of nanoplastics from water. ... Read More
The API Innovation Center (APIIC), based in St. Louis, is set to become a driving force in reshoring U.S. manufacturing of active pharmaceutical ingredients (APIs), potentially generating up to $1.2 billion ... Read More
API Innovation Center (APIIC), a non-profit organization dedicated to enabling the delivery of market-competitive commercial supply of U.S.-made active pharmaceutical ingredients (APIs) to address national health security, announced a breakthrough in ... Read More
Kansas City, Mo. – January 18, 2024 – Hart, Inc., will locate its new national headquarters in Kansas City, Missouri, announced local officials. An innovative health care data transformation company that ... Read More
The $20 million, 47,000-square-foot addition to the MU Research Reactor (MURR) facility will support its growing workforce and drive more research and development in the field of nuclear science. MU’s MURR ... Read More
Global leader in cloud software for life sciences accelerates job growth and innovation in Kansas City Veeva Systems, a global leader in cloud software for the life sciences industry, is growing ... Read More
Hedy & Hopp, a healthcare marketing agency focused on holistically activating effective and emotional connections between brands and patients, announced plans to expand in St. Louis, Missouri. The expansion is expected ... Read More
Catalent Inc., a biopharmaceutical company, recently announced plans to expand in Kansas City, Missouri. The $12 million expansion will add two new laboratories and create nearly 50 new jobs in the ... Read More
Vir Biotechnology Inc., a San Francisco-based immunology research company focused on treating and preventing serious infectious diseases, recently opened a new $41 million office within the Cortex Innovation Community in St. ... Read More